|
About the Drugs Extension User Group category
|
|
0
|
119
|
February 21, 2025
|
|
Draft for review: Drug Model Implementation Guide
|
|
3
|
46
|
April 15, 2026
|
|
Modelling inert tablets, diluents, and solvents
|
|
14
|
166
|
April 14, 2026
|
|
Semantic tag for multicomponent clinical drugs
|
|
14
|
149
|
April 12, 2026
|
|
Non-terminating strength rounding Rules
|
|
5
|
83
|
April 12, 2026
|
|
Dose form Intended sites vs. Routes of administration
|
|
23
|
313
|
April 12, 2026
|
|
Number of clinical drugs in the SNOMED International Release
|
|
5
|
69
|
April 12, 2026
|
|
DEUSG Meetings 2026
|
|
4
|
42
|
April 2, 2026
|
|
Less granular (generalized) clinical drug
|
|
2
|
68
|
March 24, 2026
|
|
Updated Medicinal Products Classes Demo
|
|
0
|
27
|
March 13, 2026
|
|
Strength Units in Botulinum Toxin Medicinal Products
|
|
2
|
31
|
March 13, 2026
|
|
|Administration of drug| versus |Drug therapy|
|
|
4
|
84
|
February 12, 2026
|
|
EDQM Dose Form Map 2026
|
|
1
|
46
|
January 28, 2026
|
|
DEUSG Meeting Notifications
|
|
4
|
76
|
December 8, 2025
|
|
Strength Numerators in Gaseous Medicinal Products
|
|
3
|
63
|
November 18, 2025
|
|
Substances for "Extracts"
|
|
7
|
129
|
October 29, 2025
|
|
Unit of Measure - rationalisation of concepts
|
|
12
|
101
|
October 20, 2025
|
|
DEUSG Meeting Notification 20th October
|
|
0
|
19
|
October 19, 2025
|
|
Increase range of has active ingredient to include microorganisms and natural products
|
|
1
|
54
|
October 16, 2025
|
|
DEUSG Meeting 9th October
|
|
0
|
26
|
October 7, 2025
|
|
DEUSG Virtual Meeting 25th September 2025
|
|
0
|
23
|
September 23, 2025
|
|
Naming Conventions for ‘Packaged Clinical Drugs’
|
|
2
|
38
|
September 16, 2025
|
|
Strength Representation in Drug Model
|
|
1
|
28
|
September 12, 2025
|
|
Hydration Subsumption
|
|
1
|
25
|
September 12, 2025
|
|
Additional Attributes for National Drug Extensions
|
|
0
|
23
|
September 10, 2025
|
|
Next DEUSG meeting
|
|
0
|
26
|
September 10, 2025
|